CONTENTS
· Invitation
· Continuing Medical Education
· Who Should Attend?
· Objectives
· Faculty
· Scientific Agenda
· Registration
· General Information
· Hotel Accommodations
· Organizer

Dear Colleague:

It is with great pleasure that we invite you to participate in European Perspectives in Urologic Oncology: A Case-Based Congress to Enhance Patient Management. This educational program will present the latest information on an array of treatment topics for the care of renal, prostate, and bladder cancer as well as insightful case discussions. Our ultimate goal is to provide you with the information needed to optimize care for your patients and to direct your attention to those trends and evolutions that are worth watching.

We are excited to be holding this year’s Congress in Barcelona. As Spain’s second largest city, Barcelona has a wealth of unique historic architecture and is one of the most popular destinations in Europe.

We look forward to welcoming you to Barcelona and sharing this important clinical information with you at this essential Congress!

Sincerely,

Peter G. Harper, MD, FRCP
Per-Uno Malmström, MD, PhD
Derek Raghavan, MD, PhD
Mark S. Soloway, MD

Congress Chairs

EACCME Accreditation

Imedex, Inc. is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

European Perspectives in Urologic Oncology: A Case-Based Conference to Enhance Patient Management is designated for a maximum of 18.0 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.

This meeting is intended for urologists, medical oncologists, radiation oncologists, surgeons, and other healthcare providers involved or interested in management of renal, bladder, and prostate cancer. No specialized knowledge other than a basic familiarity with the principles of oncology is needed to participate in this event.

After successful completion of this course, attendees should be able to:

• Comment on the newest trends in imaging and use of prognostic markers for renal, bladder, and prostate cancers
• Discuss state-of-the-art surgical advancements in urologic oncology
• Evaluate novel treatment strategies and newly approved agents for early, advanced and metastatic cases in urologic oncology
• Improve case management in the areas of radiation therapy and chemotherapy
• Identify contemporary chemotherapies for advanced disease in urologic oncology
• Apply the most up to date therapies to a wide variety of urologic cancers
  

Ferran Algaba, MD
Fundacio Puigvert
Autonomous University of Barcelona
Barcelona, Spain

Joachim Bellmunt, MD
Hospital del Mar Paseo Maritimo
Barcelona, Spain

David Breen, MD
Southampton University Hospitals
Southhampton, United Kingdom

Xavier Cathelineau, MD
Rene Descartes University
Paris, France

Gaetano Ciancio, MD, MBA
University of Miami School of Medicine
Miami, Florida, United States

Pablo de la Torre, MD
Autonomous University of Barcelona
Barcelona, Spain

Timothy Eisen, PhD, FRCP
University of Cambridge
Cambridge, United Kingdom

Bernard Escudier, MD
Institute Gustave Roussy
Villejuif, France

Detlef Frohneberg, MD
Stadisches Klinikum Karlsruhe GmbH
Karlsruhe, Germany

Peter G. Harper, MD, FRCP
Guy's & St Thomas' NHS Foundation Trust
London, United Kingdom

Guenter Janetschek, MD
Elisabethinen Hospital
Linz, Austria

Eero Kaasinen, MD, PhD
Hyvinkää Hospital
Jarvenpaa, Finland

Börje Ljungberg, MD, PhD
Umeå University Hospital
Umeå, Sweden

Per-Uno Malmström, MD, PhD
University Hospital Uppsala
Uppsala, Sweden

Haim Matzkin, MD
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel

Juan Morote, MD
Vall d'Hebron University Hospital
Barcelona, Spain

Juan Palou, MD, PhD
Fundacio Puigvert
Autonomous University of Barcelona
Barcelona, Spain

Derek Raghavan, MD, PhD
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States

Marta Sanchez-Carbayo, PhD
National Center of Oncology Investigations
Madrid, Spain

Mark S. Soloway, MD
University of Miami School of Medicine
Miami, Florida, United States

Humberto Villavicencio, MD
Fundacio Puigvert
Autonomous University of Barcelona
Barcelona, Spain

Thursday, 1 February 2007: Renal cancer

09:00
Welcome and introduction
Humberto Villavicencio, MD and Juan Palou, MD, PhD

Session I: Screening, imaging and diagnosis

09:05
What’s new in imaging and biopsy for renal cancer
Ferren Algaba, MD and Pablo de la Torre, MD

09:25
Interesting concepts in prognostic and molecular markers: Are they ready for the clinic?
Börje Ljungberg, MD, PhD

09:45
Panel discussion and questions

Session II: Surgical case issues

10:00
Radiofrequency and cryotherapy approaches for small renal tumors
David Breen, MD

10:20
Laparoscopic nephrectomy: Is there still a role for open surgery?
Guenter Janetschek, MD and Juan Palou, MD, PhD

10:40
Technique of radical nephrectomy with IVC thrombus
Gaetano Ciancio, MD, MBA

11:00
Panel discussion and questions

11:15
Break

Session III: Systemic therapy

11:35
New systemic therapies for renal cancer
Bernard Escudier, MD

11:55
Is there still a role for immunotherapy in advanced renal cancer?
Timothy Eisen, MD, PhD, FRCP

12:45
Lunch break

Session IV: Challenging cases in renal cancer

13:45
Cases
Mark S. Soloway, MD

15:45
Chair summary of day one and take home points

16:00
Adjourn

Friday, 2 February 2007: Prostate cancer

09:00
Welcome and introduction

Session V: Imaging and prognosis

09:05
Demystifying the use of PSA in practice
Juan Morote, MD

09:25
New imaging possibilities: A critical review of PET scanning
Per-Uno Malmström, MD, PhD

09:45
Lessons learned from a trial of radical prostatectomy versus watchful waiting in early prostate cancer (SPCG4)
Speaker Invited

10:05
Panel discussion and questions

10:20
Break

Session VI: Surgical issues

10:40
Debate: Surgical approaches to prostatectomy
Xavier Cathelineau, MD and Speaker Invited

11:00
Overview of non-surgical approaches for management of prostate cancer
Haim Matzkin, MD

11:20
External beam radiotherapy in prostate cancer: Opportunities for improvements
Speaker invited

11:40
Panel discussion and questions

Session VII: Challenging cases in localized prostate cancer

11:55
Cases
Mark S. Soloway, MD

13:25
Lunch

Session VIII: Systemic therapy

14:25
Development of novel compounds for prostate cancer
Speaker Invited

14:45
Use of chemotherapy in advanced prostate cancer
Derek Raghavan, MD, PhD

15:05
Panel discussion and questions

15:20
Break

Session IX: Challenging cases in advanced prostate cancer

15:40
Cases
Mark S. Soloway, MD

17:10
Chair summary of day two and take home points

17:15
Adjourn

Saturday, 3 February 2007: Bladder cancer

09:00
Welcome and introduction

Session X: Initial management

09:05
Histology of urothelial tumors
Ferran Algaba, MD

09:25
Molecular characterization of bladder cancer
Marta Sanchez-Carbayo, PhD

09:45
Break

Session XI: Surgical and systemic therapies

10:05
Endoscopic evaluation and treatment of bladder tumors
Mark S. Soloway, MD

10:25
Optimal management of Ta, T1 and CIS bladder cancer using intravesical therapy
Eero Kaasinen, MD, PhD

10:45
Should radical cystectomy be initial therapy for high grade T1 bladder cancer?
Detlef Frohneberg, MD

11:05
Systemic chemotherapy for muscle-invasive bladder cancer?
Joachim Bellmunt, MD

11:25
Panel discussion and questions

11:40
Lunch break

Session XII: Challenging cases in bladder cancer

12:45
Cases
Mark S. Soloway, MD

14:45
Break

Session XIII: Challenging cases from the audience on urologic cancers

15:15
Cases
Mark S. Soloway, MD

16:15
Chair summary of day three and take home points

16:30
Adjourn

Click here to register online.

Registration Fees
Discounted (If payment received by 7 December 2006) . . . . . . . . . . . . . . . €395
Regular (If payment received by 23 January 2007) . . . . . . . . . . . . . . . . . . €495
Full/Onsite (If payment received after 23 January 2007) . . . . . . . .. . . . . . . €595
ESMO Members* (*proof of eligibility must accompany registration) . . . . . . – €50

To Register
You may pre-register online or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment
Registration fees can be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to the registration fee to cover bank charges. Include the full name of the attendee and the name of the Congress: 271-European Perspectives in Urologic Oncology. Attendee is not registered until full payment is received.

Wire to
Bank of America NA London, 1 Alie Street, E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 16-50-50, IBAN: GB89 BOFA 1650 5095 6870 29, Beneficiary: Bank of America Domestic Deposit 5687, Account# 600895687029, Reference: Imedex, Inc. Account# 10726-118.

Registration Fee Inclusions
Registration fees include admittance to scientific sessions, Congress materials, and all functions as specified in the program.

Cancellation
For registration fees to be refunded, written notice of cancellation must be received at Imedex by 23 January 2007. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. After 23 January 2007 no refunds will be made.

Imedex does not accept responsibility for covering travel, accommodation, or any other costs incurred by registrants in the rare event that this program should be cancelled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event program content is subject to change without notice.

Registration Hours
The Registration and Information Desk will be staffed:
Friday, 19 January 2007 . . . . . . . . . . . . .11:30 – 17:15
Saturday, 20 January 2007 . . . . . . . . . . . .8:00 – 16:15

Discounted Airfare
Contact the Congress travel agent, Age of Travel, for assistance with your travel needs. Age of Travel can also accommodate pre- and post-Congress extensions.
Tel.: +1 (800) 523 4954 or +1 (404) 591 7120
Email: Imedex@ageoftravel.com

Italian Participants
Fargo International Meetings & Conventions Srl has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

Congress Location and Registration Hours
Princesa Sofia Barcelona Gran Hotel
Plaza Pio XII, 4
08028 Barcelona, Spain
Tel: + 34 93 508 1000
Fax: + 34 93 508 1001

The Imedex Registration and Information Desk will be staffed:
Thursday, 1 February 2007 . . . . . 8:00 – 16:30
Friday, 2 February 2007. . . . . . . .8:00 – 17:30
Saturday, 3 February 2007 . . . . . 8:00 – 17:00

Princesa Sofia Barcelona Gran Hotel
Plaza Pio XII, 4
08028 Barcelona, Spain
Tel: + 34 93 508 1000
Fax: + 34 93 508 1001

For the convenience of attendees, a limited number of rooms have been reserved at a rate of €160 for single occupancy or €170 double occupancy. This rate includes a daily breakfast buffet. This rate does not include VAT at 7%. This rate is not guaranteed outside the congress dates.

To reserve your room please complete this registration form and fax it to the hotel at + 34 93 411 21 06. Please note reservations will not be accepted over the phone and only by fax directly to the hotel. Reservation requests received after 5 January 2007 may not be guaranteed the group rate.

The Princesa Sofia Barcelona Gran Hotel is located on the renowned Avenue Diagonal, in the heart of Barcelona’s financial and shopping districts and just minutes from the historical center. The hotel consists of 500 well-appointed guest rooms including 25 suites. The rooms are elegantly decorated, spacious and offer all the amenities expected in a luxury hotel.

          4325 Alexander Drive
          Alpharetta, GA 30022-3740 USA
          Tel.: +1 (770) 751 7332
          Fax: +1 (770) 751 7334
          Email: meetings@imedex.com
          Web: www.imedex.com